Key points are not available for this paper at this time.
None of four chemotherapy regimens offered a significant advantage over the others in the treatment of advanced non-small-cell lung cancer.
Share your take
Add a clinician perspective alongside expert commentary.
Schiller et al. (Thu,) studied this question.